CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. - Wikidata - awgldk - TriplyDB

CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.

CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.

http://www.wikidata.org/entity/Q53254720

about

Stem cell treatment for acute myocardial infarction Stem cell treatment for acute myocardial infarction Frequency of discrepancies in retracted clinical trial reports versus unretracted reports: blinded case-control study Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease Use of mesenchymal stem cells for therapy of cardiac disease Current stem cell delivery methods for myocardial repair Bone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questions Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction Effects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.Fractalkine expression induces endothelial progenitor cell lysis by natural killer cells.Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes.Clinical trials of cardiac repair with adult bone marrow- derived cells.Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.Effects of acute and chronic endurance exercise on intracellular nitric oxide and superoxide in circulating CD34⁺ and CD34⁻ cells Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors.Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction Molecular imaging of stem cells for the treatment of acute myocardial infarction Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: a systematic review and meta-analysis.Human adipose stem cell and ASC-derived cardiac progenitor cellular therapy improves outcomes in a murine model of myocardial infarction.Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease.Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors.A Detailed Assessment of Varying Ejection Rate on Delivery Efficiency of Mesenchymal Stem Cells Using Narrow-Bore Needles.Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology.Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells.Optimized processing of growth factor mobilized peripheral blood CD34+ products by counterflow centrifugal elutriation.The advancing field of cell-based therapy: insights and lessons from clinical trials.Vascular stem cells-potential for clinical application.Comparison of human adipose-derived stem cells isolated from subcutaneous, omental, and intrathoracic adipose tissue depots for regenerative applications.Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.Cell delivery routes for stem cell therapy to the heart: current and future approaches.Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis.Key developments in stem cell therapy in cardiology.Molecular imaging: the key to advancing cardiac stem cell therapy.An update on stem cell therapies for acute coronary syndrome.PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.Current State of Stem Cell Therapy for Ischemic Heart Disease.Assessment of Myocardial Contractile Function Using Global and Segmental Circumferential Strain following Intracoronary Stem Cell Infusion after Myocardial Infarction: MRI Feature Tracking Feasibility Study.Age and Human Regenerative Capacity Impact of Cardiovascular Risk Factors

P2860

Q24186920-A31B09AF-2105-481C-8CB9-E71EAF86736F Q24203736-BD6B789A-7E1A-4D0C-B287-7A6C2EA0ECE1 Q24289040-35A80B61-850B-4B8F-A72F-D524D48DF610 Q26771257-E12604BD-BC85-4D83-A6CF-CD6DBA1FB7C4 Q26774781-44DD7069-9BE1-47B5-8FE8-1D2C6D7C4496 Q27003127-270D02C4-80C9-4E96-895C-67EEEC1B1CAD Q27004753-EC45556C-2F32-4692-B33D-B583C788E4B3 Q27026874-5C66A17D-6294-4405-9B54-28A7E84383F1 Q28082162-213CA332-D76F-41F0-A41F-C559649725F6 Q29994502-9FC64239-8497-4A0A-AF08-735649606AB9 Q33715270-4C73F17E-9112-47A2-8976-F956BDC40506 Q34062549-BE251353-E718-4C9D-9DA7-ECBC27FC0971 Q34288961-3365458B-DB47-496E-BE37-8FF0534AB0C3 Q34786321-0A3C470F-7B62-4044-8A8D-7C74DCB15C76 Q35174462-F6063BE4-5C5D-4A0A-93AD-32C207104D62 Q35217595-DA0F682A-5AE2-4B93-9B87-D20717CEC333 Q35484942-118A29A8-63B5-448C-AC8F-70BD406383FB Q35789328-2E57212D-88C9-42CA-A8E9-8BC92B1C90C8 Q35959084-936CC9EE-D694-40F8-8E0A-3FFB0F6F048A Q36169861-1C2F79CC-A706-4E31-87B8-237100FA4015 Q36244205-6EF168D3-C493-4565-A691-78C327CED6C1 Q36469490-AC353430-B4B8-4506-BED0-A67E09B5164D Q36628329-FC342219-C3CD-4854-8057-D8482434E453 Q36728564-E1CFBEB1-84D2-415C-9F1C-C8078FE10451 Q36836349-BFB6D881-C8B2-406F-BD5A-2D175CFEA1DF Q36848798-C9CCD2BF-0D6A-49D6-8547-35E525F7DD65 Q36861575-7310156A-E9FA-4704-A97D-B0B6FD115642 Q37328786-0CAA1F3D-6CDD-44DE-BC8C-915944EA04F5 Q37451512-5A90BDFE-5F8D-4C35-9BD6-F260C5FD5AD6 Q37585450-32F240FB-99CA-49E1-B28E-F9126E43F11C Q37735796-75DCC66B-1682-4D9A-9A22-66467CAF3842 Q38014708-22D67EB5-E758-47B9-83BB-B60EF61C20B8 Q38021450-17EE1B55-46E0-476B-9453-A10A1727703B Q38076435-E2A680CF-EA6B-4128-8C19-943B7474B3F1 Q38096580-1769A6D6-B95A-4DE7-A43C-22DE21FC2857 Q38235169-BD08E458-D632-4C5C-A213-4D07AE4784B2 Q38384991-BAE3FA2A-690A-480D-9904-60610EF371EC Q38697092-05BF1EC5-F117-43C6-9C63-9D5FE1480C2D Q40308084-AFB33DD1-EBB1-4022-95BB-13653C9B0013 Q40642211-9DCC6C32-F0B2-469E-97F0-6FA0F3BBE88A

P2860

CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.

http://www.wikidata.org/entity/Q53254720

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

CD34(+) cell infusion after ST ...... rfusion and is dose dependent.

@en

type

label

CD34(+) cell infusion after ST ...... rfusion and is dose dependent.

@en

prefLabel

CD34(+) cell infusion after ST ...... rfusion and is dose dependent.

@en

P1433

Q53254720-BF06FF30-A37D-4C9B-AC46-3E3B97656B52

P1476

Q53254720-56EF6A00-DAF6-4CCF-A58D-ADB5E511C99D

P2093

Q53254720-04713FC6-E5D1-4FBB-8D6A-AD3657A760A9

Q53254720-0768D5B8-1494-4794-9F8F-AC755B4B42C1

Q53254720-297D496C-B663-4D60-8735-6C7D97CFD6D3

Q53254720-49E55014-06F1-4EF8-8A77-4771BDB1D77D

Q53254720-5BE1E82C-60E6-4179-8EAA-4ACDADC7271D

Q53254720-5F5B45BA-FD54-4FFB-B3AB-51EE2E002E92

Q53254720-67EC864E-30E2-451C-8B34-8C65A40922C1

Q53254720-777A8496-FCE3-43C1-8458-6C85A9BDE885

Q53254720-7BFB3514-44C5-475D-9E1B-B133C75B9862

Q53254720-8363F946-1A9B-40F6-B890-5668FDE15A77

P304

Q53254720-6D40D301-3465-4C1D-BC92-6FC7A49EFE43

P31

Q53254720-7A371926-931F-4121-B2F7-29F22D0D3305

P356

Q53254720-23EC25B0-C7B9-41BD-B433-D791299E9C98

P407

Q53254720-00B828AC-FAD9-46F1-9858-2AD8F30E139C

P433

Q53254720-98EC6950-79F9-47FC-9C4D-92E790DEE911

P478

Q53254720-0B583B25-0185-4515-92DA-52250FE0E975

P577

Q53254720-8786C11F-94EB-46C8-A590-D2BDEEEC39FB

P698

Q53254720-AB1A53CC-07F6-4AB5-B0E9-FD7971264D1D

P356

J.AHJ.2010.09.025

P1433

American Heart Journal

P1476

CD34(+) cell infusion after ST ...... rfusion and is dose dependent.

@en

P2093

Andrew L Pecora

http://www.w3.org/2001/XMLSchema#string

Arshed A Quyyumi

http://www.w3.org/2001/XMLSchema#string

Astrid Werner

http://www.w3.org/2001/XMLSchema#string

Bernard J Gersh

http://www.w3.org/2001/XMLSchema#string

Dean Kereiakes

http://www.w3.org/2001/XMLSchema#string

Douglas Gregory

http://www.w3.org/2001/XMLSchema#string

Douglas Vaughan

http://www.w3.org/2001/XMLSchema#string

Edmund K Waller

http://www.w3.org/2001/XMLSchema#string

Emerson Perin

http://www.w3.org/2001/XMLSchema#string

Fabio Esteves

http://www.w3.org/2001/XMLSchema#string

P304

98-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AHJ.2010.09.025

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21167340

http://www.w3.org/2001/XMLSchema#string